3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Myelodysplastic Syndromes
8
Advanced Solid Tumors
8
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Neoplasms
4
Multiple Myeloma
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumour
4
Advanced Solid Tumor
4
Small Cell Lung Carcinoma
3
Recurrence
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Leukemia, Monocytic, Acute
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Malignant Solid Tumor
2
Advanced Lung Cancer
2
Interventions
Cisplatin
15
pembrolizumab
14
Magnetic Resonance Spectroscopy
13
Specimen Handling
12
Carboplatin
10
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Paclitaxel
7
durvalumab
6
Radiotherapy, Intensity-Modulated
6
Cetuximab
6
cemiplimab
5
Radiotherapy
5
Radiation
5
Pemetrexed
5
Nivolumab
5
Biopsy
5
Ipilimumab
4
Fluorouracil
4
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
4
(225)Ac-DOTA-c(RGDyK)
4
poly ICLC
3
osimertinib
3
atezolizumab
3
Taxes
3
Oxaliplatin
3
Docetaxel
3
ipatasertib
2
fludarabine phosphate
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
Injections
×
90 days
×
Clear all
No trials found.